Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5824959 | Clinical Therapeutics | 2016 | 23 Pages |
Abstract
Key factors influencing ABSSSI treatment setting were severity of infection, severity of comorbidities, and age. Clinicians surveyed identified patient profiles in which single-dose oritavancin might enable wholly outpatient or shortened inpatient management. Additional studies to elucidate the ABSSSI care pathways that include oritavancin and other novel antibiotics are needed.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Suzanne MHA, Karissa PhD, Katherine A. MPH, Iqra MSc, Charles V. MA, MD, Thomas MD, MSC-GH, Dilip MB,